Annals of Coloproctology

Letter to the Editor

Malignant disease

Reply on “Successful Conservative Management of Hepatic Portal Venous Gas due to Anastomosis Leakage After a Sigmoidectomy”: Seongwoo Hong; Ann Coloproctol. 2020;36(4):212-212. Published online August 31, 2020; DOI: https://doi.org/10.3393/ac.2019.08.12

2,629 View
42 Download

PDF

Case Report

Successful Conservative Management of Hepatic Portal Venous Gas due to Anastomosis Leakage After a Sigmoidectomy: Injae Hong, Seong Woo Hong, Yeo Gu Chang, Byungmo Lee, Woo Yong Lee, Haeng Jin Ohe, Young Ki Kim; Ann Coloproctol. 2019;35(5):282-284. Published online January 25, 2019; DOI: https://doi.org/10.3393/ac.2018.03.23.1

29,703 View
105 Download
4 Web of Science
4 Citations

Abstract PDF

In past decades, hepatic portal venous gas (HPVG) has rarely been reported, and the mortality rate has been very high. In most cases, surgical intervention was needed. Presently, abdominal computed tomography can be conveniently used to diagnose HPVG, which has various underlying causes and benign courses. We present the case of a patient with HPVG due to anastomosis leakage after a sigmoidectomy for diverticulitis; the patient was cured with conservative management.

Citations

Citations to this article as recorded by

Clinical features and management of 20 patients with hepatic portal venous gas
Yuan Zhang, Hai-Long Liu, Min Tang, Hui Wang, Hui-Hong Jiang, Mou-Bin Lin
Experimental and Therapeutic Medicine.2022;[Epub] CrossRef
Conservative treatment of hepatic portal venous gas resulting from non-occlusive mesenteric ischemia: a case report
Takuya Seike, Tusyoshi Suda, Naoki Oishi
Clinical Journal of Gastroenterology.2021; 14(5): 1404. CrossRef
Reply on “Successful Conservative Management of Hepatic Portal Venous Gas due to Anastomosis Leakage After a Sigmoidectomy”
Seongwoo Hong
Annals of Coloproctology.2020; 36(4): 212. CrossRef
Hepatic Portal Venous Gas and Anastomotic Leakage
Filippo Carannante, Gabriella Teresa Capolupo, Gianluca Mascianà, Marco Caricato
Annals of Coloproctology.2020; 36(4): 211. CrossRef

Original Articles

Expression of the Cancer Stem Cell Markers CD44 and CD133 in Colorectal Cancer: An Immunohistochemical Staining Analysis: Injae Hong, Seong Woo Hong, Yeo Goo Chang, Woo Yong Lee, Byungmo Lee, Yun Kyung Kang, You Sun Kim, In Wook Paik, Hyucksang Lee; Ann Coloproctol. 2015;31(3):84-91. Published online June 30, 2015; DOI: https://doi.org/10.3393/ac.2015.31.3.84

4,825 View
86 Download
37 Web of Science
29 Citations

Abstract PDF

Purpose

The aim of this study was to assess the expressions of CD44 and CD133 in colorectal cancer tissue by using immunohistochemical staining and to analyze the clinical significance of the expressions related to other clinicopathological data and survival results.

Methods

One hundred sixty-two patients with a biopsy-proven colorectal adenocarcinoma who were operated on between January 1998 and August 2004 were enrolled in this study. Immunohistochemical staining for CD44 and CD133 was performed on primary colorectal cancer tissue, metastatic lymph nodes, and synchronous and metachronous metastatic tumor tissues if available.

Results

CD44 expression was stronger in the primary tumor than in metastatic lymph nodes (P < 0.001), and CD133 expression tended to be stronger in primary tumor than in metastatic lymph nodes (P = 0.057). No significant correlation was found between the CD44 and the CD133 expressions. The cases with recurrence showed low expression of CD44 (P = 0.017). CD133 expression was lower in cases with elevated CA 19-9 serum levels (P = 0.028) and advanced T stage (P = 0.038). Multivariate analysis proved that low expression of CD44 was an independent prognosis factor for short disease-free survival (P = 0.028).

Conclusion

Low CD44 expression was correlated with increased tumor recurrence and short disease-free survival, and low CD133 expression was associated with advanced tumor stage. We suggest that further studies be performed to evaluate whether the immunohistochemical method for determining the CD44 and the CD133 expressions is appropriate for exploring cancer stem-cell biology in patients with colorectal cancer.

Citations

Citations to this article as recorded by

Reduction-responsive and tumor-targeted polyprodrug nanocarriers for targeting therapy of hepatocellular carcinoma
Wei Shi, Xiaoqing Xu, Jinyuan Tian, Ziyi Zhang, Zhanjun Liu
New Journal of Chemistry.2024; 48(9): 3793. CrossRef
CD44: A New Prognostic Marker in Colorectal Cancer?
Pina Ziranu, Andrea Pretta, Valentina Aimola, Flaviana Cau, Stefano Mariani, Alessandra Pia D’Agata, Claudia Codipietro, Daiana Rizzo, Veronica Dell’Utri, Giorgia Sanna, Giusy Moledda, Andrea Cadoni, Eleonora Lai, Marco Puzzoni, Valeria Pusceddu, Massimo
Cancers.2024; 16(8): 1569. CrossRef
The RNA-Binding Proteins OAS1, ZFP36L2, and DHX58 Are Involved in the Regulation of CD44 mRNA Splicing in Colorectal Cancer Cells
V. O. Novosad, D. V. Maltseva
Bulletin of Experimental Biology and Medicine.2023; 175(1): 144. CrossRef
Immunohistochemical Expression of the Stem Cell Marker CD133 in Colorectal Carcinoma
Sweta Suman, Subhransu Kumar Hota, Pranati Misra, Nageswar Sahu, Subrat Sahu
Cureus.2023;[Epub] CrossRef
Cancer stem cells: An overview of the pathophysiological and prognostic roles in colorectal cancer
Mehran Pashirzad, Thozhukat Sathyapalan, Afsana Sheikh, Prashant Kesharwani, Amirhossein Sahebkar
Process Biochemistry.2022; 115: 19. CrossRef
The presentation and regulation of the IL-8 network in the epithelial cancer stem-like cell niche in patients with colorectal cancer
Guanglin Cui, Gui Li, Zhigang Pang, Jon Florholmen, Rasmus Goll
Biomedicine & Pharmacotherapy.2022; 152: 113252. CrossRef
Expression and Prognostic Significance of Stem Cell Marker CD133 in Survival Rate of Patients with Colon Cancer
Hassan Ehteram, Fatemeh Aslanbeigi, Ebrahim Ghoochani Khorasani, Mohammad Tolouee, Hamed Haddad Kashani
Oncology and Therapy.2022; 10(2): 451. CrossRef
Cytokine-mediated crosstalk between cancer stem cells and their inflammatory niche from the colorectal precancerous adenoma stage to the cancerous stage: Mechanisms and clinical implications
Guanglin Cui, Ziqi Wang, Hanzhe Liu, Zhigang Pang
Frontiers in Immunology.2022;[Epub] CrossRef
Evaluation and Clinicopathological Correlation of CD44 in Colorectal Adenoma with Low/High-Grade Dysplasia and Carcinoma
Himanshi Bhanu, Ruchi Mittal, Sarojini Raman
Clinical Cancer Investigation Journal.2022; 11(6): 9. CrossRef
The correlation of epithelial-mesenchymal transition-related gene expression and the clinicopathologic features of colorectal cancer patients in Taiwan
Yuan-Chang Dai, Chuan-Yin Fang, Hsin-Yi Yang, Yi-Jun Jian, Shou-Chieh Wang, Yi-Wen Liu, Frédéric André
PLOS ONE.2021; 16(7): e0254000. CrossRef
Noninvasive Detection of Colorectal Carcinomas Using Serum Protein Biomarkers
Melanie M. Ivancic, Bryant W. Megna, Yuriy Sverchkov, Mark Craven, Mark Reichelderfer, Perry J. Pickhardt, Michael R. Sussman, Gregory D. Kennedy
Journal of Surgical Research.2020; 246: 160. CrossRef
Altered expression of fibroblast activation protein-α (FAP) in colorectal adenoma-carcinoma sequence and in lymph node and liver metastases
Jon Danel Solano-Iturri, Maider Beitia, Peio Errarte, Julio Calvete-Candenas, María C. Etxezarraga, Alberto Loizate, Enrique Echevarria, Iker Badiola, Gorka Larrinaga
Aging.2020; 12(11): 10337. CrossRef
The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma
Salem Y. Mohamed, Randa Mohamed Kaf, Mona Mostafa Ahmed, Amira Elwan, Hassan R Ashour, Amr Ibrahim
Journal of Gastrointestinal Cancer.2019; 50(4): 824. CrossRef
Integrative Analysis of CD133 mRNA in Human Cancers Based on Data Mining
Gui-Min Wen, Fei-Fei Mou, Wei Hou, Dan Wang, Pu Xia
Stem Cell Reviews and Reports.2019; 15(1): 23. CrossRef
The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis
Zhenpeng Wang, Yufei Tang, Lei Xie, Aiping Huang, Chunchun Xue, Zhen Gu, Kaiqiang Wang, Shaoqi Zong
Frontiers in Oncology.2019;[Epub] CrossRef
Modulation of CD44, EGFR and RAC Pathway Genes (WAVE Complex) in Epithelial Cancers
Pranathi Tata, Piyush Gondaliya, Aditya Sunkaria, Akshay Srivastava, Kiran Kalia
Current Pharmaceutical Design.2019; 25(8): 833. CrossRef
CD133 expression correlates with clinicopathologic features and poor prognosis of colorectal cancer patients
Rongyong Huang, Dan Mo, Junrong Wu, Huaying Ai, Yiping Lu
Medicine.2018; 97(23): e10446. CrossRef
DNA mismatch repair and CD133-marked cancer stem cells in colorectal carcinoma
Phaik-Leng Cheah, Jing Li, Lai-Meng Looi, Kean-Hooi Teoh, Diana Bee-Lan Ong, Mark J. Arends
PeerJ.2018; 6: e5530. CrossRef
CD133 and CD44 as cancer stem cell markers in bladder carcinoma
Rania ES. Wasfy, Dina M. El-Guindy
Egyptian Journal of Pathology.2017; 37(1): 204. CrossRef
Expression of epithelial-mesenchymal transition and cancer stem cell markers in colorectal adenocarcinoma: Clinicopathological significance
Ji Eun Choi, Jun Sang Bae, Myoung Jae Kang, Myoung Ja Chung, Kyu Yun Jang, Ho Sung Park, Woo Sung Moon
Oncology Reports.2017; 38(3): 1695. CrossRef
Targeted photodynamic therapy as potential treatment modality for the eradication of colon cancer and colon cancer stem cells
Natasha Hodgkinson, Cherie A Kruger, Heidi Abrahamse
Tumor Biology.2017; 39(10): 101042831773469. CrossRef
Prognostic value of pretreatment serum carbohydrate antigen 19-9 level in patients with colorectal cancer: A meta-analysis
Zhan Yu, Zhen Chen, Jian Wu, Zhong Li, Yugang Wu, Surinder K. Batra
PLOS ONE.2017; 12(11): e0188139. CrossRef
Temporal and spatial changes of cells positive for stem-like markers in different compartments and stages of human colorectal adenoma-carcinoma sequence
Guanglin Cui, Gang Xu, Li Zhu, Zhigang Pang, Wei Zheng, Zhenfeng Li, Aping Yuan
Oncotarget.2017; 8(28): 45311. CrossRef
A comparison of cancer stem cell markers and nonclassical major histocompatibility complex antigens in colorectal tumor and noncancerous tissues
Rabia Bilge Özgül Özdemir, Alper Tunga Özdemir, Fatih Oltulu, Kamile Kurt, Gürkan Yiğittürk, Cengiz Kırmaz
Annals of Diagnostic Pathology.2016; 25: 60. CrossRef
Implications of OCT4 in breast carcinoma from initiation to lymph node metastasis
Hoda H. Abou Gabal, Riham M. Abu-Zeid, Maissa N. El-Maraghy
Egyptian Journal of Pathology.2016; 36(2): 194. CrossRef
CD133 expression may be useful as a prognostic indicator in colorectal cancer, a tool for optimizing therapy and supportive evidence for the cancer stem cell hypothesis: a meta-analysis
Yang Zhao, Jing Peng, Enlong Zhang, Ning Jiang, Jiang Li, Qi Zhang, Xuening Zhang, Yuanjie Niu
Oncotarget.2016; 7(9): 10023. CrossRef
Prognostic significance of CD44 in human colon cancer and gastric cancer: Evidence from bioinformatic analyses
Pu Xia, Xiao-Yan Xu
Oncotarget.2016; 7(29): 45538. CrossRef
Clinical Implication of Colorectal Cancer Stem Cells: Still Has a Long Way to Go
Hungdai Kim
Annals of Coloproctology.2015; 31(3): 79. CrossRef
Advances and perspectives of colorectal cancer stem cell vaccine
Mei Guo, Jun Dou
Biomedicine & Pharmacotherapy.2015; 76: 107. CrossRef

Matrix Metalloproteinase-2 and -7 Expression in Colorectal Cancer: Seong Woo Hong, Yun Kyung Kang, Byungmo Lee, Woo Yong Lee, Yeo Gu Jang, In Wook Paik, Hyucksang Lee; J Korean Soc Coloproctol. 2011;27(3):133-139. Published online June 30, 2011; DOI: https://doi.org/10.3393/jksc.2011.27.3.133

5,035 View
35 Download
20 Citations

Abstract PDF

Purpose

Matrix metalloproteinase-2 (MMP-2) and MMP-7 have been implicated in tumor growth and metastasis. This study aimed to investigate the expressions of MMP-2 and -7 in colorectal cancer and to evaluate their values as prognostic markers.

Methods

Immunohistochemical staining for MMP-2 and -7 was done in 144 resected colorectal cancer specimens. Clinicopathological data and survival results were compared with regard to the expression results.

Results

The expression rates of MMP-2 in tumor cells in the tumor center and the tumor border were 16.7% and 38.9%, respectively. That of MMP-2 in stromal cells was 27.8%. MMP-7 immunoreactivities of tumor cells in the tumor center and the tumor border were 6.9% and 23.6%. The expressions of MMP-2 and MMP-7 were correlated. MMP-2 expression in stromal cells was more increased in the distal part of the colorectum: 8.8% in right colon cancer, 29.5% in left colon cancer and 36.4% in rectal cancer. MMP-2 expression of tumor cells in the tumor border was correlated with T-stage. MMP-7 expression of tumor cells in the tumor border was increased in case of infiltrative cancer compared with fungating tumor. The expression patterns of MMP-2 and -7 were not correlated with other clinicopathological factors, including tumor markers, node metastasis, distant metastasis, lymphatic invasion, tumor differentiation, and recurrence. No significant associations between the overall and disease-free survival rates and the MMP-2 and -7 expression patterns were noted.

Conclusion

The high expression rates of MMP-2 and -7 in tumor borders suggest that MMP-2 and -7 have some role in tumor invasion, but in this study, MMP-2 and -7 did not appear to be significant predictors of prognosis in colorectal cancer.

Citations

Citations to this article as recorded by

A review of matrix metalloproteinase-2-sensitive nanoparticles as a novel drug delivery for tumor therapy
Lanlan Zong, Hongliang Xu, Huiqi Zhang, Ziwei Tu, Xiao Zhang, Shumin Wang, Meigui Li, Yu Feng, Binke Wang, Luhui Li, Xinmei Xie, Zhonggui He, Xiaohui Pu
International Journal of Biological Macromolecules.2024; 262: 130043. CrossRef
Prognostic value of integrin αV expression and localization pattern in invasive breast carcinomas
Otto Luiz Dutra Cerqueira, Mayara Carolline Silva Botelho, Ana Paula Zen Petisco Fiore, Cynthia Aparecida Bueno de Toledo Osório, Rebeka Tomasin, Mauro César Cafundó Morais, Rossana Verónica Mendoza López, Elaine Cristina Cardoso, Santiago Andres Vilella-
Neoplasia.2022; 30: 100803. CrossRef
Effect of ginger extracts on colorectal cancer HCT-116 cell line in the expression of MMP-2 and KRAS
Shiva Malmir, Asa Ebrahimi, Frouzandeh Mahjoubi
Gene Reports.2020; 21: 100824. CrossRef
Proteome Heterogeneity in Colorectal Cancer
Lay Cheng Lim, Yang Mooi Lim
PROTEOMICS.2018;[Epub] CrossRef
Implications of Isoprostanes and Matrix Metalloproteinase-7 Having Potential Role in the Development of Colorectal Cancer in Males
Mahmood Rasool, Arif Malik, Ahmad Ashar Ghuman, Muhammad Abdul Basit Ashraf, Mahwish Arooj, Sulayman Waquar, Sara Zahid, Sumera Shaheen, Aamer Qazi, Muhammad Imran Naseer, Mazin A. Zamzami, Ayat Al-Ghafari, Othman A. Baothman, Mustafa Zeyadi, Nawal Helmi,
Frontiers in Oncology.2018;[Epub] CrossRef
Circulating gelatinases are not prognostic of treatment response and survival in locally advanced rectal cancer patients undergoing preoperative chemoradiotherapy
Sukran Ulger, Diclehan Kilic, Fatih Demircioglu, Canan Y Demirtas, Ozge T. Pasaoglu
Journal of Cancer Research and Therapeutics.2018; 14(Suppl 1): S90. CrossRef
Profile of Expression of Genes Encoding Matrix Metallopeptidase 9 (MMP9), Matrix Metallopeptidase 28 (MMP28) and TIMP Metallopeptidase Inhibitor 1 (TIMP1) in Colorectal Cancer: Assessment of the Role in Diagnosis and Prognostication
Zbigniew Lorenc, Dariusz Waniczek, Katarzyna Lorenc-Podgórska, Wiktor Krawczyk, Maciej Domagała, Mateusz Majewski, Urszula Mazurek
Medical Science Monitor.2017; 23: 1305. CrossRef
Matrix Metalloproteinase-2 and -9, Lactate, and Malate Dehydrogenase and Lipid Peroxides in Sera of Patients with Colorectal Carcinoma
Kristina Gopcevic, B. Rovcanin, D. Kekic, Z. Krivokapic, V. Dragutinovic
Folia Biologica.2017; 63(5-6): 190. CrossRef
Prognostic significance of plasma matrix metalloprotease-2 in pancreatic cancer patients
Nidhi Singh, Surabhi Gupta, Ravindra M. Pandey, Peush Sahni, Shyam S. Chauhan, Anoop Saraya
Indian Journal of Medical Research.2017; 146(3): 334. CrossRef
CD147 and matrix-metalloproteinase-2 expression in metastatic and non-metastatic uveal melanomas
Julia Lüke, Vlatka Vukoja, Tim Brandenbusch, Khaled Nassar, Jens Martin Rohrbach, Salvatore Grisanti, Matthias Lüke, Aysegül Tura
BMC Ophthalmology.2016;[Epub] CrossRef
High Expression of Matrix Metalloproteinases: MMP-2 and MMP-9 Predicts Poor Survival Outcome in Colorectal Carcinoma
Nada Salem, Ibrahim Kamal, Jaudah Al-Maghrabi, Adel Abuzenadah, Abdul Ali Peer-Zada, Yousif Qari, Mahmoud Al-Ahwal, Mohammed Al-Qahtani, Abdelbaset Buhmeida
Future Oncology.2016; 12(3): 323. CrossRef
Rab11-FIP2 promotes colorectal cancer migration and invasion by regulating PI3K/AKT/MMP7 signaling pathway
Chang-long Xu, Jian-zhang Wang, Xuan-ping Xia, Chen-wei Pan, Xiao-xiao Shao, Sheng-long Xia, Shou-xing Yang, Bo Zheng
Biochemical and Biophysical Research Communications.2016; 470(2): 397. CrossRef
Shikonin inhibits the cell viability, adhesion, invasion and migration of the human gastric cancer cell line MGC-803 via the Toll-like receptor 2/nuclear factor-kappa B pathway
Ji Ping Liu, Dan Liu, Jun Fei Gu, Mao Mao Zhu, Li Cui
Journal of Pharmacy and Pharmacology.2015; 67(8): 1143. CrossRef
Prognostic significance of MMP-7 expression in colorectal cancer: A meta-analysis
Da-wei Sun, Ying-yi Zhang, Yue Qi, Xing-tong Zhou, Guo-yue Lv
Cancer Epidemiology.2015; 39(2): 135. CrossRef
Immunoexpression of metalloproteinase 14 and tissue inhibitor of metalloproteinase 2 in colorectal carcinomas and lymph node metastases
Francisco Nélson Nóbrega Furtado, João Paulo Aguiar Sampaio, João Tarcisio Alves Maia-Filho, Renato Braga Vieira, Roberto César Pereira Lima-Júnior, Ronaldo Albuquerque Ribeiro, Paulo Roberto Carvalho Almeida
Comparative Clinical Pathology.2015; 24(6): 1367. CrossRef
MMP-2/9-oriented combinations enhance antitumor efficacy of EGFR/HER2-targeting fusion proteins and gemcitabine
YE QIN, XIU-JUN LIU, LIANG LI, XU-JIE LIU, YI LI, RUI-JUAN GAO, RONG-GUANG SHAO, YONG-SU ZHEN
Oncology Reports.2014; 32(1): 121. CrossRef
Prognostic Role of Tumor-Associated Proteases in Colorectal Cancer
N. E. Kushlinskii, E. S. Gershtein, E. A. Korotkova, V. V. Prorokov
Bulletin of Experimental Biology and Medicine.2013; 154(3): 365. CrossRef
Novel roles of liver sinusoidal endothelial cell lectin in colon carcinoma cell adhesion, migration and in-vivo metastasis to the liver
Yunfei Zuo, Shuangyi Ren, Min Wang, Biao Liu, Juntao Yang, Xuezhang Kuai, Changwei Lin, Dianyuan Zhao, Li Tang, Fuchu He
Gut.2013; 62(8): 1169. CrossRef
Patterns of FOXE1 Expression in Papillary Thyroid Carcinoma by Immunohistochemistry
Andrey Bychkov, Vladimir Saenko, Masahiro Nakashima, Norisato Mitsutake, Tatiana Rogounovitch, Alyaksandr Nikitski, Florence Orim, Shunichi Yamashita
Thyroid.2013; 23(7): 817. CrossRef
Matrix metalloproteinase 2 overexpression and prognosis in colorectal cancer: a meta-analysis
Mumu Shi, Bo Yu, Hongguo Gao, Jingwen Mu, Changwei Ji
Molecular Biology Reports.2013; 40(1): 617. CrossRef

First
Prev
Page of 1
Next
Last

Search